PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 71 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $126,000 | -89.2% | 20,261 | -90.1% | 0.00% | -100.0% |
| Q3 2015 | $1,169,000 | -41.4% | 204,462 | -23.5% | 0.00% | -33.3% |
| Q2 2015 | $1,994,000 | +159.3% | 267,245 | +107.9% | 0.00% | +200.0% |
| Q1 2015 | $769,000 | -63.1% | 128,573 | -55.4% | 0.00% | -75.0% |
| Q4 2014 | $2,086,000 | +5115.0% | 288,458 | +3512.5% | 0.00% | – |
| Q3 2013 | $40,000 | +81.8% | 7,985 | +58.5% | 0.00% | – |
| Q2 2013 | $22,000 | – | 5,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Phocas Financial Corp. | 1,033,328 | $6,376,000 | 0.68% |
| ARDSLEY ADVISORY PARTNERS LP | 650,000 | $4,011,000 | 0.63% |
| Worth Venture Partners, LLC | 138,357 | $853,000 | 0.47% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,242,503 | $13,836,000 | 0.46% |
| HIGHLAND CAPITAL MANAGEMENT LP | 716,880 | $4,423,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,543,386 | $34,203,000 | 0.22% |
| Point72 Asset Management, L.P. | 5,858,749 | $36,148,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 1,298,723 | $8,013,000 | 0.19% |
| Fosun International Ltd | 472,580 | $2,750,000 | 0.18% |
| J. Goldman & Co LP | 400,000 | $2,468,000 | 0.17% |